Dr. Stephen D. Loyd, M.D., newly appointed Director of the West Virginia Office of Drug Control Policy for the state Department of Human Services (DoHS), on Sunday told the Legislature’s Joint Committee on Children and Families about reducing prenatal drug exposure.
In the 25-minute presentation, Dr. Loyd, former opioid czar and director of Tennessee’s Substance Abuse Services office, commended West Virginia’s efforts and approaches to prenatal drug exposure. He reiterated earlier comments he made about the state’s framework, structure, and approach to prenatal drug exposure.
He mentioned three areas of emphasis to address substance-exposed infants:
· Increasing awareness, use, and availability of long-acting reversible contraception (LARC) methods, such as the intrauterine device (IUD) and the birth-control implants, which he noted are highly effective in preventing pregnancy. (He prefaced his comments by saying about 50% of pregnancies in the United States are “unintended,” although he said the number climbs to “99.999%” among pregnant mothers who are involved in substance abuse.
· “Tying together” West Virginia’s existing services for unwed mothers.
· Addressing stigma.
Dr. Loyd said West Virginia leads the nation in Neonatal Abstinence Syndrome (NAS) and Intrauterine Substance Exposure (IUSE), with NAS affecting 6.7% percent of births and IUSE affecting 8.8% of births.
While NAS cases have declined since their peak in 2017, IUSE rates continue to rise, reflecting national trends, he said.
He said the difference between NAS and IUSE, although both are caused by substance abuse during pregnancy, is that NAS can be treated more easily.
“Addressing the issue of substance-exposed infants is not only a priority for the Office of Drug Control Policy but also a vital step in securing a healthier future for West Virginians. By increasing the utilization of treatment programs and preventative services, we can begin to turn the tide on this epidemic and protect the most vulnerable among us,” Dr. Loyd said.
Dr. Loyd cited several DoHS interventions and their effectiveness, noting West Virginia leads the nation in terms of programs and services, including many local or regional programs.
Among the programs cited were:
Maternal Risk Screening: The West Virginia Prenatal Risk Screening Instrument (WV PRSI) is a mandatory tool administered during a woman’s first obstetric visit, ensuring early identification and referral for high-risk conditions, including substance use.
Drug Free Moms and Babies (DFMB): The DFMB program is administered by the West Virginia Perinatal Partnership and integrates medical and behavioral health care with comprehensive recovery support services. The program’s impact is evident, with 74.9% of participants testing positive for substance use at baseline and 64.2% testing negative at delivery.
Residential Treatment: Seven residential treatment programs across the state provide specialized care for pregnant women, mothers, and their children, offering a safe environment for recovery. The programs are in Cabell, Wood, Fayette, and Kanawha counties.
Home Visitation Programs: Available at no cost to families from pregnancy through age 5, the programs include evidence-based models, such as Parents as Teachers and Healthy Families America, providing critical support to new and expecting mothers.
Describing his experience with substance abuse, Dr. Loyd said a major aspect of interventions is stigma or efforts to punish mothers-to-be either by eliminating drugs such as methadone for use with the condition or, he said, the lack of programs or the use of traditional rather than innovative approaches, especially for LARC, or attempts by health care providers and medical personnel and policymakers to “drive the problem underground.”
At the conclusion of the meeting, House Co-chair Margitta Mazzocchi of Logan County commended Dr. Loyd, saying his presentation focused on responsibilities of those involved, including the medical profession, policymakers, and expectant mothers and “for all of us to be compassionate.” |